Sucralose enhances GLP-1 release and lowers blood glucose in the presence of carbohydrate in healthy subjects but not in patients with type 2 diabetes

被引：0
|
作者：
S Temizkan
O Deyneli
M Yasar
M Arpa
M Gunes
D Yazici
O Sirikci
G Haklar
N Imeryuz
D G Yavuz
机构：
[1] Marmara University Faculty of Medicine,Department of Endocrinology and Metabolic Diseases
[2] Istanbul,Department of Biochemistry
[3] Turkey,Department of Gastroenterology
[4] Marmara University Faculty of Medicine,undefined
[5] Istanbul,undefined
[6] Turkey,undefined
[7] Marmara University Faculty of Medicine,undefined
来源：
European Journal of Clinical Nutrition | 2015年 / 69卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：162 / 166
页数：4
相关论文
共 50 条
  • [21] Liraglutide, a human GLP-1 analogue, reduces systolic blood pressure in subjects with type 2 diabetes
    Colagiuri, S.
    Frid, A.
    Zdravkovic, M.
    Le-Thi, T. D.
    Vaag, A.
    Garber, A.
    Zinman, B.
    DIABETOLOGIA, 2008, 51 : S359 - S360
  • [22] GLP-1 Action and Glucose Tolerance in Subjects With Remission of Type 2 Diabetes After Gastric Bypass Surgery
    Jimenez, Amanda
    Casamitjana, Roser
    Viaplana-Masclans, Judith
    Lacy, Antonio
    Vidal, Josep
    DIABETES CARE, 2013, 36 (07) : 2062 - 2069
  • [23] Similar elimination rates of GLP-1 in obese type 2 diabetic patients and matched healthy subjects
    Vilsboll, T
    Krarup, T
    Holst, JJ
    DIABETES, 2002, 51 : A344 - A344
  • [24] GLP-1 Enhances Insulin Biosynthesis in Type 2 Diabetic Subjects during Hyperglycemia
    Chen, Zijian
    Jayatillake, Harsha
    Cruikshank, Greg
    Zheng, Bing Na
    Hovorka, Roman
    Rogatsky, Eduard
    Stein, Daniel T.
    DIABETES, 2011, 60 : A94 - A94
  • [25] IV GLP-1 lowers blood glucose levels in NIDDM patients regardless of fasting glucose, BMI, and insulin capacity
    ToftNielsen, H
    Madsbad, S
    Holst, JJ
    DIABETOLOGIA, 1997, 40 : 503 - 503
  • [26] Lack of effect of sucralose on glucose homeostasis in subjects with type 2 diabetes
    Grotz, VL
    Henry, RR
    McGill, JB
    Prince, MJ
    Shamoon, H
    Trout, JR
    Pi-Sunyer, X
    JOURNAL OF THE AMERICAN DIETETIC ASSOCIATION, 2003, 103 (12) : 1607 - 1612
  • [27] Near normalisation of blood glucose improves the potentiating effect of GLP-1 on glucose-induced insulin secretion in patients with type 2 diabetes
    P. V. Højberg
    M. Zander
    T. Vilsbøll
    F. K. Knop
    T. Krarup
    A. Vølund
    J. J. Holst
    S. Madsbad
    Diabetologia, 2008, 51 : 632 - 640
  • [28] Near normalisation of blood glucose improves the potentiating effect of GLP-1 on glucose-induced insulin secretion in patients with type 2 diabetes
    Hojberg, P. V.
    Zander, M.
    Vilsboll, T.
    Knop, F. K.
    Krarup, T.
    Volund, A.
    Holst, J. J.
    Madsbad, S.
    DIABETOLOGIA, 2008, 51 (04) : 632 - 640
  • [29] Beneficial effect of the GLP-1 analogue liraglutide on blood pressure and cardiovascular biomarkers in subjects with Type 2 diabetes
    Vilsboell, T.
    Zdravkovic, M.
    Le-Thi, T.
    Krarup, T.
    Schmitz, O.
    Courreges, J.
    Verhoeven, R.
    Buganova, I.
    Madsbad, S.
    DIABETIC MEDICINE, 2007, 24 : 3 - 3
  • [30] Five weeks of treatment with the GLP-1 analogue liraglutide improves glycaemic control and lowers body weight in subjects with type 2 diabetes
    Nauck, M. A.
    Hompesch, M.
    Filipczak, R.
    Le, T. D. T.
    Zdravkovic, M.
    Gumprecht, J.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2006, 114 (08) : 417 - 423
12345